# About this desk

> About peptidebarbie — Skin & Aesthetics Research Peptides — About peptidebarbie: an independent, citation-first digest of the Skin & Aesthetics research peptides literature — how sources are chosen, how anecdote is separated from evidence, and what this desk deliberately will not do.

**SKIN & AESTHETICS / EDITORIAL**

A playful name attached to a strict method: cite the study, state the population, name the limit, and never let an appealing claim travel without its caveat.

## What this site is

peptidebarbie is an independent literature digest covering three compounds that share a category: the GLOW research blend, GHK-Cu, and Melanotan II. It exists because the skin-and-aesthetics corner of peptide writing is unusually noisy — the mechanisms are genuinely interesting, the marketing is enthusiastic, and the gap between the two is rarely marked on the page.

The name is a wink at how this category gets sold. The content is not. Every page is built the same way: describe the compound accurately, explain the mechanism in plain language, report what the cited studies actually measured and in which species, then separate that cleanly from what only communities report. Where the evidence is strong, it says so. Where a controlled trial does not exist — and for one of these three, none does — it says that instead, in the same sentence as the appealing claim rather than three paragraphs later.

Nothing here is for sale. No compound is sourced, recommended or supplied, and no page carries a protocol.

## How to read these pages

Three conventions run across the site, and knowing them makes every page faster to read.

**Bracketed numbers are sources.** Every `[N]` maps to an entry on the [references page](/references), with authors, journal, year and a link. Quantitative claims — percentages, subject counts, durations, effect sizes — carry a citation or they do not appear.

**Community reports are labelled and quarantined.** Each compound page has a section that opens by stating the material is anecdotal, not clinical evidence. That material comes from forums, community guides and published qualitative studies of online discussion. It is included because it describes what people actually experience and report, and it is separated because it is not measurement. It never carries a dose.

**Study doses are reported as the study reported them.** When a page states that 10 men received 0.025 mg/kg subcutaneously in a crossover trial [16], that is a description of an experiment, not guidance. This desk names no dose, schedule or route for any person, ever.

## Where this desk stops

The limits are as much a part of the editorial stance as the citations.

This site does not evaluate suppliers, compare product quality, or comment on where anything can be obtained — and given that analytical studies of online melanotan products repeatedly find inaccurate labelling and unverifiable content, the sourcing question is one the literature answers badly enough on its own. It does not give medical advice, assess whether a cited finding applies to any individual, or interpret anyone's results.

It also does not pretend the evidence is better than it is. Two of the three compounds covered here are unapproved research chemicals, one blend has never been tested as a blend, and the best-evidenced compound on the site is supported by small studies with a well-documented delivery problem. Readers seeking clinical guidance should bring these questions to a licensed clinician in their own jurisdiction.

---

An independent reading desk for the skin, hair and pigmentation peptide literature, where every enthusiastic sentence arrives with a citation and a caveat attached — not a clinic, not a vendor, not a prescription.